Adult stem cells are harvested from the patient's own bone marrow, not from fetal or embryonic sources.
While embryonic stem cells are procured from a developing embryo at the blastocyst stage, adult stem cells are found in all tissues of the growing human being, and have the potential to transform into most of the other cell types.
"Stem Cell Therapy could eventually eliminate the need for joint replacement,” says Dr. Einhorn. Rather than surgically replacing joints, as has been the standard medical approach in the past, therapies of the future will focus on the use of stem cells and gene therapy in the new scientific field of tissue re-engineering. "It's the future of our specialty," adds Dr. Einhorn.
Thomas A. Einhorn, M.D., is Chairman of the Department of Orthopaedic Surgery, and Professor of Orthopaedic Surgery, Biochemistry and Biomedical Engineering at Boston University. Since 1982, he has practiced as a leading surgeon specializing in reconstructive surgery of the hip and knee in Boston and New York.
For two years, Dr. Einhorn has been performing successful breakthrough surgery to reduce the progression, and, in many cases, eliminate Avascular Necrosis of the Hip, utilizing a safe, innovative Bone Marrow Aspiration Concentration technique to grow new bone from the patient's own stem cells procured from bone marrow. Involving the direct inoculation of autologous bone marrow stem cells, which reduces the risk of rejection, Dr. Einhorn states, “The success rate is highest when the disease is diagnosed in its early stages.”
Internationally acclaimed as a leader in the field of regenerative medicine, an area heralded as the future of orthopaedics, Dr. Thomas A. Einhorn has bee
Copyright©2009 Vocus, Inc.
All rights reserved